J
Juan Morote
Researcher at Hebron University
Publications - 23
Citations - 501
Juan Morote is an academic researcher from Hebron University. The author has contributed to research in topics: Prostate cancer & Prostate-specific antigen. The author has an hindex of 11, co-authored 23 publications receiving 479 citations.
Papers
More filters
Journal ArticleDOI
Effect of inflammation and benign prostatic enlargement on total and percent free serum prostatic specific antigen.
TL;DR: Inflammation has an important prevalence in cancer–free prostatic biopsy specimens and seems to have no significant influence on total and percent free serum PSA, however, prostatic size seems to be the major contributor.
Journal ArticleDOI
Clinical Efficacy of Bone Alkaline Phosphatase and Prostate Specific Antigen in the Diagnosis of Bone Metastasis in Prostate Cancer
TL;DR: The clinical use of bone alkaline phosphatase enzyme determined by radioimmunoassay and PSA measurement for the diagnosis of bone metastases and progression of prostate cancer is recommended because of the good sensitivity and specificity.
Journal ArticleDOI
Osteoporosis during Continuous Androgen Deprivation: Influence of the Modality and Length of Treatment
TL;DR: Androgen suppression increases the prevalence of osteoporosis in patients with prostate cancer and the modality of continues androgen suppression seems not to affect its prevalence, however the length of androgens suppression would be related to its development.
Journal ArticleDOI
Failure to maintain a suppressed level of serum testosterone during long-acting depot luteinizing hormone-releasing hormone agonist therapy in patients with advanced prostate cancer.
Juan Morote,S. Esquena,Jose M. Abascal,Enrique Trilla,Luis Cecchini,Carles X. Raventós,Roberto Catalán,Jaume Reventós +7 more
TL;DR: A small but clinically significant rate of patients under 3-month luteinizing hormone-releasing hormone agonist therapy fail to achieve or maintain castrate testosterone serum levels, which supports the need of monitoring testicular response during LH-RH agonists therapy.
Journal ArticleDOI
Expression of Androgen, Oestrogen α and β, and Progesterone Receptors in the Canine Prostate: Differences between Normal, Inflamed, Hyperplastic and Neoplastic Glands
F. Gallardo,Teresa Mogas,Teresa Baró,R.M. Rabanal,Juan Morote,Miguel Abal,Jaume Reventós,Josep Lloreta +7 more
TL;DR: The expression of receptor for androgen, oestrogen α and β (ERα and ERβ) and progesterone (PR) was examined immunohistochemically in canine prostate specimens (normal, hyperplastic, inflamed [prostatitis] or neoplastic).